
|Articles|April 1, 2016
Pharmacy Times Week in Review: April 1, 2016
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.
Advertisement
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.
Featured article:
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Implementing Enfortumab Vedotin-ejfv Plus Pembrolizumab: Navigating Safety Data and the Pharmacist’s Role
2
Improving Outcomes in Diffuse B-Cell Lymphoma Requires Multidisciplinary Evolution
3
Key Data, Interviews at the 2025 ASH Annual Meeting and Exposition
4
Long-Term BENEFIT Data Affirm Isa-VRd as Standard of Care in Transplant-Ineligible NDMM
5

















































































































































































































